HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pertuzumab brake for prostate cancer?

AuthorsJane Bradbury
JournalThe Lancet. Oncology (Lancet Oncol) Vol. 8 Issue 4 Pg. 287 (Apr 2007) ISSN: 1470-2045 [Print] England
PMID17431951 (Publication Type: News)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Receptor, ErbB-2
  • pertuzumab
Topics
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Clinical Trials, Phase II as Topic
  • Humans
  • Male
  • Prostatic Neoplasms (drug therapy, pathology)
  • Receptor, ErbB-2 (immunology)
  • Survival Analysis
  • Treatment Outcome
  • Tumor Burden (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: